Wednesday, June 10, 2026
🇺🇸 FDA

P1 · Therapeutic area intelligence

Oncology patent intelligence

Anticancer agents, immuno-oncology, ADC, and oncology patent filings — grants, expirations, and assignee activity.

Patents
2,004

Quick answer

2,004 US pharmaceutical patents in our index match Oncology title keywords (A61K/A61P). Cross-link to related drug therapeutic-area hubs and company patent portfolios for full IP context.

  1. US 7790433

    Compositions of prokaryotic phenylalanine ammonia-lyase and methods of treating cancer using compositions thereof

    BIOMARIN PHARMACEUTICAL INC. · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 7790860

    Targeting and imaging tumor vasculature using conjugates that bind to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue Sep 07 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 7781413

    SEMA3B inhibits tumor growth and induces apoptosis in cancer cells

    The Board of Regents of the University of Texas System · Granted Tue Aug 24 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 19 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 7776607

    Mammalian selenoprotein differentially expressed in tumor cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 7777019

    Mutated Anti-CD22 antibodies with increased affinity to CD22-expressing leukemia cells

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Aug 17 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 12 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 7767689

    Carboline derivatives useful in the treatment of cancer

    PTC THERAPEUTICS, INC. · Granted Tue Aug 03 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 7763719

    Variants of humanized anti-carcinoma MAb CC49

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 7763292

    Cancer cell growth inhibition by black bean (Phaseolus vulgaris L) extracts

    INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 7763586

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 7759081

    Annexin proteins and autoantibodies as serum markers for cancer

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 7754206

    Method for treating cancer using a Notch4 ligand antagonist

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jul 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 7749967

    Peptides of a melanoma antigen and their use in diagnostic, prophylactic, and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 7749719

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jul 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 7744931

    Methods for treating oral cancers with herbal compositions

    The Board of Regents of the University of Texas System · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 7745212

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 29 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 24 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 7732576

    Tumor suppressor designated TS10Q23.3

    The Board of Regents of the University of Texas System · Granted Tue Jun 08 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 03 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 7723104

    Cancer specific promoters

    The Board of Regents of the University of Texas System · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 7723496

    Preventives/remedies for cancer

    Takeda Pharmaceutical Company Limited · Granted Tue May 25 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 20 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 7718684

    Methods and materials for assessing prostate cancer therapies and compounds

    The Regents of the University of California · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 7718170

    Alkaline phosphatase compositions to reduce skin cancer

    Essential Skincare, LLC · Granted Tue May 18 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 13 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7713710

    Isolation and use of solid tumor stem cells

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7713939

    Illudin analogs useful as antitumor agents

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7714109

    Combinations and kits for cancer treatment using selected antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7714014

    Targeting GLI proteins in human cancer by small molecules

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7713526

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted Tue May 11 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 06 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7709443

    Cyclic peptide antitumor agents

    Northwestern University · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7709609

    Tumor suppressor gene, p47ING3

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue May 04 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 29 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7704701

    Diagnosis of prostate cancer with SPAS-1 cancer antigen

    The Regents of the University of California · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7704962

    Small oligonucleotides with anti-tumor activity

    The Board of Regents of the University of Texas System · Granted Tue Apr 27 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 22 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7700274

    Compositions and methods in cancer associated with altered expression of KCNJ9

    Sagres Discovery, Inc. · Granted Tue Apr 20 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7696159

    Treatment for basal cell carcinoma

    Graceway Pharmaceuticals. LLC · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7696306

    Compositions and methods for preventing or treating cancer

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Tue Apr 13 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7691380

    Combined methods for tumor coagulation and tumor treatment

    The Board of Regents of the University of Texas System · Granted Tue Apr 06 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Apr 01 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7682607

    Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas

    The Regents of the University of California · Granted Tue Mar 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7678552

    Method for selecting therapeutic agents for cancer treatment

    Precision Therapeutics, Inc. · Granted Tue Mar 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7670767

    Genetic alterations associated with cancer

    The Board of Regents of the University of Texas System · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7670599

    YKL-40 as a marker and prognostic indicator for cancers

    The Regents of the University of California · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7666989

    Recombinant protein having an anti-cancer effect, its encoding gene and uses thereof

    Beijing Sunbio Biotech Co. Ltd. · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7666581

    Methods for preparing compositions comprising heat shock proteins useful for the treatment of cancer and infectious disease

    University of Connecticut Health Center · Granted Tue Feb 23 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 18 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7662395

    Method of enhancing a targeted immune response against tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7659071

    Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN

    The Board of Regents of the University of Texas System · Granted Tue Feb 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7655695

    Illudin analogs useful as anticancer agents

    The Regents of the University of California · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7655397

    Selections of genes and methods of using the same for diagnosis and for targeting the therapy of select cancers

    The United States of America, as represented by the Department of Health and Human Services · Granted Tue Feb 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 28 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7651847

    Methods of oligosaccharide profiling for the detection of cancer

    The Regents of the University of California · Granted Tue Jan 26 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 21 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7648826

    Detecting CYP24 expression level as a marker for predisposition to cancer

    The Regents of the University of California · Granted Tue Jan 19 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 14 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7645441

    Compositions and methods in cancer associated with altered expression of PRLR

    Sagres Discovery, Inc. · Granted Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7641902

    Compositions and methods for detecting cancer and for inhibiting metastasis

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jan 05 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 31 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7632814

    HYD1 peptides as anti-cancer agents

    The Regents of the University of California · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many Oncology patents are indexed?

2,004 patents match our Oncology classifier (title keywords in USPTO records).

Is this legal or medical advice?

No — patent intelligence is for professional reference. Verify expiration and FTO with qualified patent counsel and primary USPTO records.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.